860129W

C18:0-d7 Fuc-GM1 Ceramide (d18:1/18:0-d7)

from synthetic

• Synonym(e): C18:0-d7 Fuc-GM1 Ganglioside ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4Glcb-Ceramide(d18:1/18:0-d7))
• Empirische Formel (Hill-System): C₇₉H₁₃₄D₇N₃O₃₅
• Molekulargewicht: 1700.01
• UNSPSC-Code: 12352211

Eigenschaften

• Biologische Quelle: synthetic
• Assay: ≥99% (TLC)
• Form: methanol solution
• Verpackung: pkg of 1 × 100 μg (860129W-100UG)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand
• Lipid-Typ: sphingolipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O[C@@H]3OC(CO)[C@H](O)C(O[C@@H]4OC(CO)[C@H](O)C(O)C4O[C@@H]4OC(C)[C@@H](O)C(O)C4O)C3NC(C)=O)C(O[C@@]3(CC(O)[C@@H](NC(C)=O)C(O3)[C@H](O)[C@H](O)CO)C(O)=O)C2O)C(O)C1O)C(O)\C=C\CCCCCCCCCCCCC

Beschreibung

Anwendung

Lipids research

Verpackung

2 mL Amber Glass Sealed Ampule (860129W-100UG)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS02,GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H225,H301 + H311 + H331,H370
• P-Sätze: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• Gefahreneinstufungen: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Zielorgane: Eyes,Central nervous system
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 2
• Flammpunkt (°F): 49.5 °F - closed cup
• Flammpunkt (°C): 9.7 °C - closed cup